You are required to be logged in to access the full website
Click here if you have forgotten your username or password
17 June 2026 - Optimi Health Corp (NASDAQ:OPTH) (CSE:OPTI) (FSE:8BN0), a commercial-stage GMP pharmaceutical manufacturer of regulated psychedelic drug products, announced on Tuesday that it has completed production of two microdose psilocybin finish...
17 June 2026 - Medical radioisotopes manufacturer Niowave Inc and Ratio Therapeutics Inc, a clinical-stage pharmaceutical company developing radiopharmaceuticals for cancer treatment, announced on Tuesday a supply agreement for Actinium-225.Under thi...
17 June 2026 - 4E Therapeutics Inc, a neuroscience company developing next-generation treatments for chronic pain, announced on Tuesday that it has been acquired by US pharmaceutical company Eli Lilly and Company (NYSE:LLY).This acquisition combines ...
16 June 2026 - Innoviva Specialty Therapeutics, a subsidiary of Innoviva Inc (Nasdaq:INVA) focused on innovative therapies in critical care and infectious disease, said on Tuesday that it has entered into an exclusive distribution and licensing agree...
16 June 2026 - Swedish biotech company AlzeCure Pharma AB (Nasdaq First North Premier Growth Market:ALZCUR) on Tuesday reported positive results from the completed Phase Ib clinical study of ACD856, its lead NeuroRestore drug candidate being develope...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe